# Kymera Therapeutics Inc. (KYMR) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$349M |
| 2024 | -$262M |
| 2023 | -$166M |
| 2022 | -$161M |
| 2021 | -$101M |
| 2020 | -$46M |
| 2019 | -$42M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$84M |
| 2025-09-30 | -$93M |
| 2025-06-30 | -$85M |
| 2025-03-31 | -$74M |
| 2024-09-30 | -$72M |
| 2024-06-30 | -$51M |
| 2024-03-31 | -$58M |
| 2023-09-30 | -$58M |
| 2023-06-30 | -$43M |
| 2023-03-31 | -$45M |
| 2022-09-30 | -$45M |
| 2022-06-30 | -$41M |
| 2022-03-31 | -$37M |
| 2021-09-30 | -$29M |
| 2021-06-30 | -$25M |
| 2021-03-31 | -$13M |
| 2020-09-30 | -$8M |
| 2020-06-30 | -$14M |
| 2020-03-31 | -$11M |
| 2019-09-30 | -$12M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/KYMR/operating-income)